BioMed Valley Discoveries, Inc
10 clinical trials · Sponsor
◉ Watch BioMed Valley Discoveries, Inc
| Record | Firm | Date |
|---|---|---|
| Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies (NCT05221320) | BioMed Valley Discoveries, Inc | 2022-05-26 |
| Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations (NCT04488003) | BioMed Valley Discoveries, Inc | 2021-01-07 |
Track BioMed Valley Discoveries, Inc automatically
Every clearance here is in the API, with alerts when new ones post.